New 'all-tablet' treatment shows promise for common form of leukemia
An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...
FierceBiotech2h
Denali eyes approval after Hunter syndrome drug clears safety measures, reduces biomarkers in open-label study
After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
Hudson Valley One15h
IV therapy, hot yoga & cool smoothies at Woodstock Infusions
The owners and staff of Woodstock Infusions (L-R): manager Tania Cawthron, owner and registered nurse Kim Rice, founder and owner Marc Baumslag and registered nurse Anna Schlosser. (Photos by Lauren ...
The Greeley Tribune19h
‘Solutions exist’: Immersiv Health opens in Greeley, offering low-cost ambulatory infusion treatment
A Greeley clinic hopes to provide a less costly alternative for patients in need of infusions or injections of medications.
Le Lézard20h
New England Journal of Medicine Publishes Results of Global, Multicenter eNRGy Study Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer
Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the New England Journal ...
Kauppalehti20h
New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer
The publication reviews the results of 204 patients with 12 tumor types enrolled and treated on the eNRGy study, concluding “Zenocutuzumab demonstrated durable efficacy in patients with advanced NRG1+ ...